Zebrafish study uncovers how IGF signalling sculpts the lymphatic system

A new study in Cell Reports reveals how insulin-like growth factor (IGF) signalling shapes lymphatic vessel development in zebrafish. Researchers found that this pathway coordinates interactions between blood and lymphatic systems to maintain vascular health. The findings could open doors for future treatments in diseases like lymphedema, though human applications remain distant.

The team used zebrafish models to track lymphatic and blood vessel growth in real time. Fluorescent labelling allowed them to observe how IGF signalling directs lymphatic endothelial cells during vessel formation. When IGF levels were disrupted, lymphatic vessels failed to branch properly, resulting in abnormal structures.

RNA sequencing pinpointed the genes and molecular networks activated by IGF stimulation. These pathways influence cell proliferation, migration, and specialisation—key steps in forming functional lymphatic vessels. The study also showed that IGF signalling must stay within a precise range; too much or too little led to defective vessel patterns.

Zebrafish offered a clear advantage over traditional lab models. Their transparency and fast genetic testing sped up experiments, letting researchers screen potential IGF-targeted compounds efficiently. While the results suggest modulating IGF could aid lymphatic repair, no human trials for lymphedema exist yet. Current IGF research focuses mainly on cancer, diabetes, and muscle disorders, with no registered studies for lymphatic conditions as of February 2026.

The study highlights IGF signalling as a critical regulator of lymphatic development. Zebrafish models have provided a faster way to explore its mechanisms, though human therapies are still far off. For now, the findings lay groundwork for future research into lymphatic disorders and possible drug targets.